N. P. Sert

UvA-DARE (Digital Academic Repository) A manifesto for reproducible science

Christopher D. Chambers, Brian A. Nosek, E. Wagenmakers, 2016 .

Maximising the output of osteoarthritis research: the ARRIVE guidelines.

N. P. Sert, 2012 .

Olvanil: A non-pungent TRPV1 activator has anti-emetic properties in the ferret

P. Andrews, J. Rudd, C. Yeung, 2010, Neuropharmacology.

A manifesto for reproducible science

John P. A. Ioannidis, Christopher D. Chambers, Marcus R. Munafò, 2017, Nature Human Behaviour.

Olvanil : A non-pungent TRPV 1 activator has antiemetic properties in the ferret Kit -

P. Andrews, J. Rudd, C. Yeung, 2011 .

The Ferret in Nausea and Vomiting Research: Lessons in Translation of Basic Science to the Clinic

P. Andrews, N. P. D. Sert, N. P. Sert, 2014 .

Improving the reporting of animal research: when will we ARRIVE?

N. P. D. Sert, N. P. Sert, 2011 .

The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments)

P. Flecknell, M. Macleod, B. McColl, 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT3 receptor antagonists

N. Percie du Sert, P. Andrews, J. Rudd, 2010, Cancer Chemotherapy and Pharmacology.

The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret

P. Andrews, J. Rudd, R. Moss, 2009, Neuroscience Letters.

Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT3 receptor antagonists

J. Rudd, C. Apfel, P. Andrews, 2010, Cancer Chemotherapy and Pharmacology.